EMGALITY PEN (galcanezumab-gnlm)

120 mg/mL subcutaneous pen injector

• Inject 120 mg by subcutaneous route once a month in the abdomen, thigh, outer upper arm, or buttocks

Migraine prevention

• Inject 120 mg by subcutaneous route once a month in the abdomen, thigh, outer upper arm, or buttocks

• Inject 1 milliliter (120 mg) by subcutaneous route once a month in the abdomen, thigh, outer upper arm, or buttocks

• Inject 2 milliliters (240 mg) as 2 consecutive 120 mg injections by subcutaneous route once in the abdomen, thigh, outer upper arm, or buttocks (using 2 separate injection sites)

• Inject 240 mg as 2 consecutive 120 mg injections by subcutaneous route once in the abdomen, thigh, outer upper arm, or buttocks (using 2 separate injection sites)